Coldpine
 

Brad Knott Stock Trades

U.S. Representative · R · NC-13

Disclosures through Feb 25

Every stock trade Brad Knott has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Brad Knott · Sold $ORMP · Jan 10 · $15K–$50K

0.28LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.350.38

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Brad Knott

Get an email the moment Brad Knott discloses a new trade. Free, no card, no spam.

Follow free →
3
Disclosed trades
2
Buys
1
Sells
2
Unique tickers

Most-traded tickers

CMPO2ORMP1

Disclosure record

46
Median days to disclose
25
House median
66.7%
Disclosed after 45 days
46
Longest gap, days

Brad Knott has 3 trades on record with both a trade date and a disclosure date. The median one was disclosed 46 days after the trade, against a median of 25 days across the House. Of the 171 members with three or more dated trades, 25 have a longer median.

2 of them (66.7%) were disclosed more than 45 days after they were made, the STOCK Act's reporting window; across the House the share is 4.2%. A late report is a missed filing deadline, not a finding about the trade. Dated trades on record run from Jan 10, 2025 to Jan 14, 2025.

By the owner field on each report, every one of the 3 trades is reported as the member's own.

Lag is the disclosure date minus the trade date, from the filing itself. Trades with a missing or implausible date (outside 0 to 1,000 days) are left out of the lag figures. How every member compares: the STOCK Act late-filer study; how the data is built: methodology.

Filings all 1All filings, newest first

Recent disclosed trades

DateTickerAssetTypeAmount
Jan 14CMPO
CompoSecure, Inc. - Class A Common Stock (CMPO)
buy$1K–$15K
Jan 10ORMP
Oramed Pharmaceuticals Inc. - Common Stock (ORMP)
sell$15K–$50K
Jan 10CMPO
CompoSecure, Inc. - Class A Common Stock (CMPO)
buy$1K–$15K

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →